Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study
NCT01076361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 370
Last updated 2014-10-27
Summary
The Medtronic CapSure Epi Lead Post-approval Study will assess long-term safety of the 4968 lead. This study is part of the Medtronic System Longevity Study.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
4968 Clinical Trial Leader · Medtronic
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
Countries
- United States
- Australia
- Austria
- Belgium
- Canada
- Denmark
- France
- Germany
- Italy
- Netherlands
- Serbia and Montenegro
- Spain
- Sweden
- Switzerland
Study Locations
More Related Trials
-
AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol
NCT01786486 ·Status: COMPLETED
-
A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter
NCT05373862 ·Status: COMPLETED ·Phase: NA
-
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
NCT01196923 ·Status: COMPLETED ·Phase: PHASE4
-
Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study: The LAAPITUP 2 Study
NCT01504451 ·Status: UNKNOWN ·Phase: PHASE4
-
APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias
NCT00170274 ·Status: COMPLETED ·Phase: NA
-
Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation
NCT04190186 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
NCT00971204 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias
NCT04750798 ·Status: RECRUITING
-
Atrial Fibrillation Algorithms Clinical Validation Study
NCT04699812 ·Status: COMPLETED ·Phase: NA
-
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
NCT06165510 ·Status: RECRUITING ·Phase: NA
-
Abbott Ventricular Tachycardia PAS
NCT05839873 ·Status: ACTIVE_NOT_RECRUITING
-
Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study
NCT01246466 ·Status: COMPLETED ·Phase: NA
-
CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
NCT01984346 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
NCT04076917 ·Status: TERMINATED
-
Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study
NCT05099289 ·Status: COMPLETED ·Phase: NA
-
AF Substrate Mapping and Guided Ablation
NCT02571218 ·Status: COMPLETED ·Phase: NA
-
3-Dimensional Mapping System: The PULSTAR Study
NCT05618340 ·Status: COMPLETED ·Phase: NA
-
CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF
NCT04239534 ·Status: WITHDRAWN ·Phase: NA
-
Amplify EP Registry
NCT06669637 ·Status: NOT_YET_RECRUITING
-
Jewel Electrophysiology (EP) Lab Study
NCT05490459 ·Status: COMPLETED ·Phase: NA
-
Applause Study I - Append System Early Feasibility Study
NCT07278869 ·Status: RECRUITING ·Phase: NA
-
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
NCT03795298 ·Status: COMPLETED ·Phase: NA
-
AMPLATZER Cardiac Plug Clinical Trial
NCT01118299 ·Status: COMPLETED ·Phase: NA
-
Wide Area Circular Ablation Versus Extra-wide Area Circular Ablation in Persistent Atrial Fibrillation
NCT02814136 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures
NCT02768051 ·Status: WITHDRAWN ·Phase: NA